Eflornithine (DFMO) Prevents Progression of Pancreatic Cancer by Modulating Ornithine Decarboxylase Signaling

類似資料

• Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma
  著者:: Rao, Chinthalapally V., 等
  出版事項: (2015)
• EGFR inhibitor gefitinib prevents progression of pancreatic lesions to carcinoma in a conditional LSL-Kras(G12D/+) transgenic mice model
  著者:: Mohammed, Altaf, 等
  出版事項: (2010)
• Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression
  著者:: Mohammed, Altaf, 等
  出版事項: (2015)
• Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling
  著者:: Mohammed, Altaf, 等
  出版事項: (2013)
• Chemoprevention of urothelial cell carcinoma growth and invasion by the dual COX-LOX inhibitor licofelone in UPII-SV40T transgenic mice
  著者:: Madka, Venkateshwar, 等
  出版事項: (2014)